LINC02122

Across TCGA pan-cancer cohorts, LINC02122 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of LINC02122’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where LINC02122 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02122 is over-expressed in tumor, although a few such as HNSC and KIRC show the opposite, repressed pattern.

LUAD, BLCA, and HNSC are the cancer types where LINC02122 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02122 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	Female	All	+0.994	<.001	7	view →
BLCA	All	All	+1.112	.009	5	view →
HNSC	All	II,III,IV	−0.114	.005	4	view →
BRCA	Female	All	+0.070	.036	4	view →
KIRC	All	II,III,IV	−0.024	.005	4	view →
KICH	Female	All	+0.060	.013	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

LINC02122–LUAD

Open the LUAD breakdown →